Clinical valuation of ST changes in a group of patients with ventricular arrhythmias: The inSighT Study.

Abstract

BackgroundThe inSighT study was designed to determine the prevalence of ischemic changes as recorded by implantable cardioverter–defibrillator (ICD) ST deviations in intracardiac electrocardiograms (EGM) over the 24 h preceding malignant ventricular arrhythmias (VT/VF).MethodsThe study enrolled patients with known coronary artery disease (CAD) or high risk of future development of CAD implanted with an ICD equipped with an ST monitoring feature (Ellipse™/Fortify Assura™, St. Jude Medical). Device session records were collected at each in‐clinic follow‐up. EGM ST levels of the beats over the 15 minutes prior to VT/VF events were compared using a t test with those from a baseline period of 23–24 h prior to the VT/VF event. All events with p < .05 were visually inspected to confirm they were evaluable; additional criteria for exclusion from further analysis included inappropriate therapy, aberrant conduction, and occurrence of VT/VF within 24h prior to the current event.ResultsThe study enrolled 481 ICD patients (64 ± 11 years, 83% male) in 14 countries and followed them for 15±5 months. A total of 165 confirmed VT/VF episodes were observed, of which 71 events (in 56 patients, 34% of all patients with VT/VF) were preceded by significant (p < .05) ST‐segment changes unrelated to known non‐ischemic causes. None of the analyzed demographic and clinical factors proved to be associated with greater odds of presenting with ST‐segment changes prior to VT/VF episode.ConclusionIn this exploratory study, characteristic ST‐segment changes, likely representative of ischemic events, were observed in 34% of all patients with VT/VF episodes.